Microbot Medical Q1 2023 Earnings Report $1.85 +0.05 (+2.78%) As of 04:00 PM Eastern Earnings HistoryForecast Microbot Medical EPS ResultsActual EPS-$0.36Consensus EPS -$0.45Beat/MissBeat by +$0.09One Year Ago EPSN/AMicrobot Medical Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AMicrobot Medical Announcement DetailsQuarterQ1 2023Date5/17/2023TimeN/AConference Call ResourcesMBOT Earnings History Microbot Medical Earnings HeadlinesMicrobot Medical regains Nasdaq compliance with bid priceJanuary 27 at 9:00 PM | msn.comMicrobot Medical (NASDAQ:MBOT) Stock Price Expected to Rise, HC Wainwright Analyst SaysJanuary 27 at 2:44 AM | americanbankingnews.comIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coincidence. On January 17, the U.S. Supreme Court upheld a ban on TikTok — a China-based app regarded as the largest intelligence gathering tool of the CCP [Chinese Communist Party].January 30, 2025 | Brownstone Research (Ad)Microbot Medical Authorizes Special Bonus for CEOJanuary 27 at 2:07 AM | americanbankingnews.comMicrobot Medical approves special CEO bonusJanuary 24, 2025 | msn.comMicrobot Medical stock target raised to $9 by H.C. WainwrightJanuary 24, 2025 | msn.comSee More Microbot Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Microbot Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Microbot Medical and other key companies, straight to your email. Email Address About Microbot MedicalMicrobot Medical (NASDAQ:MBOT), a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.View Microbot Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Upcoming Earnings AbbVie (1/31/2025)AON (1/31/2025)Colgate-Palmolive (1/31/2025)Chevron (1/31/2025)Eaton (1/31/2025)W.W. Grainger (1/31/2025)Novartis (1/31/2025)Snowflake (1/31/2025)Itaú Unibanco (2/2/2025)NXP Semiconductors (2/3/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
